BLOCKBUSTER: This has huge implications!
From Jon Eisen:
PLEASE SHARE WIDELY.
The attached document was released to lawyer Sue Grey after a request under the Official Information Act as stated in the also attached letter.
It shows Medsafe declined full approval of the Pfizer mRNA vaccine (so called) due to insufficient safety, efficacy and product integrity data.
This information is at odds with Prime Minister and Minister of Health propaganda/PR which claims that the Pfizer Vaccine is safe and effective.
I refer to specific text in the attached document:
Page 73 (seventh paragraph)
Due to the unresolved concerns and additional quality, safety and efficacy data to be provided
at the time of completion of the evaluation, Medsafe is unable to recommend that this product
be granted consent. It is therefore recommended that the application be referred to the
Medicines Assessment Advisory Committee (MAAC) under section 22(2) of the Medicines Act
1981 for their consideration. In referring the application, it is requested that the MAAC focus
on the specific aspects in their consideration of the application:
Page 69 Final Recommendation
A number of quality issues, and some clinical issues arising from this application still remain
unresolved. The applicant has committed to providing the outstanding information to address
these issues, with many of these issues aligning with the EMA/CHMPs specific obligations
that were listed in the EU’s conditional approval. Due to this outstanding information the
product cannot be recommended for consent under Section 20 of the Medicines Act 1981 for
distribution in New Zealand. However, due to the COVID-19 global pandemic situation and the
clinical need for the product, provisional consent under Section 23 of the Medicines Act 1981
may be considered for the following indication:
How dare they claim this jab is safe based on just one month trial and how dare they force government employees and others to choose between their job and their health based on misleading and decorative claims.
Martin’s note: The attached document referred to wasn’t included in the communication, but clearly this is a vital item to share. I’ll update as more becomes available.